NEW YORK, NY — As Breast Cancer Awareness Month unfolds across the globe, a stark reality often remains obscured by the broader narrative of early detection and successful recovery: metastatic breast cancer (MBC). On October 13, National Metastatic Breast Cancer Awareness Day, the nonprofit organization METAvivor Research and Support will spearhead its most ambitious global initiative to date. More than 325 landmarks across 20 countries, 195 cities, and all 50 U.S. states will be illuminated in the signature colors of MBC—teal, green, and pink—to demand attention, spark conversation, and, most crucially, fund the research that serves as the only hope for those living with the disease.
The #LightUpMBC campaign is not merely a visual spectacle; it is a strategic effort to shift the public perception of breast cancer. While campaigns focused on "pink ribbons" have successfully boosted early screening rates, those living with Stage 4 disease often feel isolated by a cultural conversation that focuses primarily on "survivorship" and "curing" the disease. For the MBC community, there is no cure—only the ongoing battle for time.
The Reality of Stage 4: Defining the Crisis
Metastatic breast cancer occurs when cancer cells spread from the original site in the breast to distant organs, most commonly the bones, liver, lungs, or brain. It is vital to understand that even when the cancer has migrated, it remains breast cancer; a patient with bone metastases is not suffering from bone cancer, but from breast cancer that has traveled.
For many, the diagnosis is a shock that arrives years after an initial treatment for early-stage breast cancer. For others, it is a primary diagnosis, known as de novo metastatic breast cancer. In either scenario, the prognosis is sobering. Unlike early-stage cancers, which may be treated with the hope of total eradication, MBC is treated with the goal of management. Patients remain on systemic therapies for the rest of their lives, hoping to control the growth of tumors and extend their time with family.
The attrition rate of these treatments is a constant shadow over patients’ lives. Cancer cells frequently develop resistance to therapies, forcing patients to cycle through different regimens—chemotherapy, hormone therapy, targeted therapy, or immunotherapy—until those options are exhausted. The human cost is staggering: in the United States alone, an estimated 42,670 people are expected to lose their lives to breast cancer in 2026, averaging approximately 117 deaths every single day.
Chronology: From a Single Landmark to a Global Beacon
The genesis of #LightUpMBC is deeply personal. The campaign was founded by Laura Inahara, who sought to honor the memory of her best friend, Jessica Moore, who passed away from metastatic breast cancer at the age of 36.
- 2017: The movement began with a single landmark—the Memorial Bridge in Portsmouth, New Hampshire. It was a modest but powerful tribute that transformed the local landscape.
- 2018–2025: Driven by the passion of the MBC community, the campaign expanded exponentially. Each year, more city councils, landmark boards, and private building owners joined the cause, recognizing the importance of highlighting the "hidden" population of breast cancer patients.
- October 13, 2026: The campaign reaches its current zenith, with over 325 landmarks participating. From the iconic heights of New York City’s One World Trade Center and Chicago’s Willis Tower to the natural wonder of Niagara Falls and the historic Ness Bridge in Inverness, Scotland, the world will glow to signify a collective demand for scientific breakthroughs.
Supporting Data: Why Research is the Only Path Forward
The financial reality of cancer research often dictates the pace of discovery. METAvivor has carved out a unique position in the non-profit landscape by exclusively funding Stage 4 metastatic breast cancer research.
Unlike many other organizations that divide their resources across prevention, early detection, and survivorship, METAvivor focuses 100% of its research grants on the deadliest form of the disease. This is a critical distinction: while prevention and screening are essential for the general population, the 117 people dying daily need immediate, high-impact clinical research that can provide new, life-extending therapies.
Through a rigorous, two-tier peer-review process—incorporating both top-tier scientists and patient advocates—METAvivor ensures that every dollar donated is directed toward projects with the highest potential for clinical impact. To date, the #LightUpMBC campaign has raised over $2.7 million, a figure that is directly converted into laboratory research and clinical trials that are currently being pursued by scientists across the globe.
Official Perspectives: The Voices Behind the Lights
The leadership of METAvivor reflects the very community they serve. Dr. Kelly Shanahan, the organization’s Board President, has been living with metastatic breast cancer since 2013. Her survival—now reaching 13 years—is a testament to the advancements in research, though she remains acutely aware of the fragility of her situation.
"When I was diagnosed with metastatic breast cancer in 2013, I certainly didn’t think I’d still be here 13 years later," Dr. Shanahan remarked. "My hope and the hope of so many others lies in research. METAvivor-funded research is increasingly important these days, and #LightUpMBC is the biggest contributor to this effort. It serves not only as our primary fundraiser but as a vital way to bring us together as a community."
Founder Laura Inahara emphasizes the legacy of the campaign’s inspiration, Jessica Moore. "Jessica hoped to illuminate one local landmark. Today, her legacy helps families around the world shine a light for the people they love, teaches patients with MBC how to advocate for themselves, and has raised millions for critical research. It proves that one person’s desire to be seen can transform into a global movement."
Implications: The #LightUpMBC Live Experience
On October 13, at 8 p.m. ET / 5 p.m. PT, the #LightUpMBC campaign culminates in a free, global livestream. Hosted by Tami Eagle Bowling—who has lived with MBC for 11 years—and Broadway star and breast cancer survivor Kara Lindsay, the event serves as a digital town hall for the MBC community.
The production is designed to be both educational and deeply humanizing. Viewers can expect:
- Patient Stories: Direct accounts from people living with Stage 4, streamed live from various illuminated landmarks.
- Scientific Insights: Presentations from leading researchers regarding the current status of clinical trials and therapeutic breakthroughs.
- Artistic Tribute: A lineup of performances featuring Tony Award winner Victoria Clark, nominee Dorian Harewood, actress Christina Bianco, and songwriter Cassandra Kubinski.
The event will be broadcast via the METAvivor YouTube channel and Facebook Live, with additional reach through the LiveOne platform. The organizers have made it clear that the goal is not just to entertain, but to drive donations. One hundred percent of net proceeds from the campaign and the livestream will go directly toward funding future research grants.
Conclusion: A Call to Action
As the sun sets on October 13, the sight of hundreds of buildings turning teal, green, and pink will serve as a global reminder that metastatic breast cancer is not a distant, clinical abstraction. It is a daily reality for hundreds of thousands of people.
The #LightUpMBC campaign invites the public to participate in a simple but meaningful way: by visiting these landmarks, capturing images, and sharing them on social media with the tags @LightUpMBC, #LightUpMBC, and #METAvivor. By doing so, they amplify the voices of those who are often silenced by their diagnosis.
For those interested in contributing to the mission of transforming Stage 4 breast cancer into a manageable, chronic condition rather than a terminal one, the path is clear. Through the combined power of public awareness, artistic expression, and rigorous scientific funding, the #LightUpMBC movement continues to illuminate the path toward a future where patients no longer have to live in fear of their next scan.
For more information, to find a list of participating landmarks, or to contribute to the research fund, please visit www.lightupmbc.org.
About the Author
